CVR 43007068Private limited company (ApS)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)København NFounded 21 Jan 2022
Dandex has recorded no changes to this company since it began following the register.
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about Solid Therapeutics ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexEmployees
3
CVR registry, Aug 2026
-3 (-50%) over 12 months
Gross profit
-1.7M
DKK, annual report 2025
Result
-4.4M
DKK, annual report 2025
Equity
-15.4M
DKK, annual report 2025
Anne Mette Hyldgaard Trauelsen20% to under 25% of capital and votes, since 21 Jan 2022
Receptor Holding ApSCVR 39115476, 20% to under 25% of capital and votes, since 21 Jan 2022
and 5 moreJohn Sørensen Haurumsince 21 Feb 2022
Equity was negative at 31 Dec 2025: -15.4M DKK. Dandex estimate, computed 6 Nov 2026.
10% to under 15% of capital and votessince 21 Jan 2022
10% to under 15% of capital and votesnotified 1 Feb 2023since 21 Jan 2022
20% to under 25% of capital and votesnotified 1 Feb 2023since 21 Jan 2022
CVR 3911547620% to under 25% of capital and votessince 21 Jan 2022
CVR 3978649420% to under 25% of capital and votessince 21 Jan 2022
CVR 4295668610% to under 15% of capital and votessince 21 Jan 2022
10% to under 15% of capital and votesnotified 1 Feb 2023since 21 Jan 2022
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
21 Jan 2022 to 6 Nov 2026.
1 Feb 2023 to 6 Nov 2026.
Aug 2026, monthly: 3 employees, 1 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | May 2022 | Jun 2022 | Jul 2022 | Aug 2022 | Sep 2022 | Oct 2022 | Nov 2022 | Dec 2022 | Jan 2023 | Feb 2023 | Mar 2023 | Apr 2023 | May 2023 | Jun 2023 | Jul 2023 | Aug 2023 | Sep 2023 | Oct 2023 | Nov 2023 | Dec 2023 | Jan 2024 | Feb 2024 | Mar 2024 | Apr 2024 | May 2024 | Jun 2024 | Jul 2024 | Aug 2024 | Sep 2024 | Oct 2024 | Nov 2024 | Dec 2024 | Jan 2025 | Feb 2025 | Mar 2025 | Apr 2025 | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 3 | 4 | 4 | 4 | 4 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 5 | 5 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| FTE | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's own headcount as CVR records it, not the annual report's average, which may cover a group. Monthly May 2022 to Aug 2026.
Latest Aug 2026, published 21 Oct 2026. Source: CVR employment series (Årsbeskæftigelse, Kvartalsbeskæftigelse, Månedsbeskæftigelse).
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Gross profit | -398 | -2,739 | -4,214 | -1,688 |
| Operating profit | -762 | -4,193 | -7,247 | -4,052 |
| Result for the year | -797 | -3,483 | -6,758 | -4,356 |
| Equity | -757 | -4,240 | -10,998 | -15,354 |
| Total assets | 3,575 | 10,813 | 11,004 | 6,842 |
| Employees (average) | 1 | 2 | 4 | 3 |
| Credit metrics (Dandex calculations) | ||||
| Employee growth (vækst i antal ansatte) | Not reportednote 1 | 100% | 100% | -25% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | 645 | 4,425 | 11,396 | 15,790 |
| ROIC (afkast af investeret kapital) | Not reportednote 1 | -8,778.3%note 2 | -1,935.1%note 2 | -757.7%note 2 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group. Not every period is a full year: 2022 covers 11 months (21 Jan to 31 Dec 2022). Changes against it compare periods of different length.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may. No cash flow statement filed (class A and B are exempt).
Each registered value from the day it took effect, newest first.
From CVR, read 6 Nov 2026. Text such as the signing rule and purpose is shown as registered.
6 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Direktion:
Fratrådte:
Anne Mette Hyldgaard Trauelsen, (adm. dir), den 28.08.2025.
Tiltrådte:
John Sørensen Haurum, (adm. dir), den 28.08.2025.
Vedtægter ændret: 11.06.2024
Vedtægter ændret: 07.12.2023
Revision:
Tiltrådte:
CVR-NR. 33167288 LPOG ApS STATSAUTORISEREDE REVISORER, Kilde Alle 22, 3600 Frederikssund, den 07.12.2023.
Vedtægter ændret: 01.02.2023
Nyt navn: Solid Therapeutics ApS
Direktion:
Fratrådte:
John Sørensen Haurum, den 01.02.2023.
Tiltrådte:
Anne Mette Hyldgaard Trauelsen, (adm. dir), den 01.02.2023.
Vedtægter ændret: 21.02.2022
Direktion:
Fratrådte:
Claus Haase, den 21.02.2022.
Tiltrådte:
John Sørensen Haurum, den 21.02.2022.
Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem eller af den samlede bestyrelse i forening.
Stiftelsesdato: 21.01.2022.
Virkningsdato: 21.01.2022.
Seneste vedtægtsdato: 21.01.2022.
Kapital:
kr. 40.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 40.000,00 til kurs 100,00, fuldt indbetalt.
Stiftere:
Thomas Michael Frimurer, den 21.01.2022, Claus Haase, den 21.01.2022, John Sørensen Haurum, den 21.01.2022, Stine Helene Falsig Petersen, den 21.01.2022, Thue Walter Schwartz, den 21.01.2022, Anne Mette Hyldgaard Trauelsen, den 21.01.2022, Hagop Youssoufian, den 21.01.2022.
Bestyrelse:
John Sørensen Haurum, (formand), den 21.01.2022, Claus Haase, den 21.01.2022, Thue Walter Schwartz, den 21.01.2022.
Direktion:
Claus Haase, den 21.01.2022.
Selskabet tegnes af en direktør i forening med formanden for bestyrelsen
Første regnskabsår:
21.01.2022 - 31.12.2022.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er at udøve aktiviteter indenfor fund af lægemidler og udvikling heraf.
1 registered in CVR.
P-number 1027937930Ole Maaløes Vej 3, 2200 København N
No other current company drawn.
No other current company drawn.
